Karnawati Innovation (531671)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

At ₹2.11, Karnawati Innovation looks like a statistical bargain that would make Graham pause. A P/E of 2.18 and a market cap of only ₹12 crore against latest quarterly sales of ₹71 crore suggest the market is giving almost no credit to the business. But I must ask: why? The book value is a thin ₹0.21 per share, so a P/B near 10 means there is no asset cushion. The celebrated ROE of 353.94% is not a sign of a wonderful franchise; it is an arithmetic mirage of a tiny equity base. ROCE of 20.72% is more credible, but with sales growth flat at 0.00%, the company is not compounding its top line. Profit growth of 1000.00% is the usual base-effect tease; one quarter does not make an enterprise. Latest quarter net profit of ₹2 crore on ₹71 crore sales is a razor-thin 2.8% margin. With zero dividend and promoter holding not disclosed, I cannot judge whether minority shareholders are being treated fairly. Piotroski F-Score of 6/9 is acceptable but hardly a clean bill of health. This looks like a possible turnaround—a cigar butt with one puff left. If the profitability persists, the valuation is absurdly cheap; if it is a working-capital illusion or a cyclical blip, the low price can get lower. I would need audited annual numbers, cash flow statements, and management answers before investing. In a ₹12 crore micro-cap, liquidity and governance risks are high. Graham would demand a clear margin of safety in tangible assets, not just earnings power. I will watch this from the sidelines unless the business proves it can grow sales and sustain margins.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer